{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-335157","form_type":"8-K","ticker":"AURA","cik":"0001501796","company_name":"Aura Biosciences, Inc.","filed_at":"2026-08-05T20:15:40+00:00","discovered_at":"2026-08-05T20:17:03.354038+00:00","generated_at":"2026-08-05T20:17:30.012962+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aura Biosciences stockholders approve increase in authorized shares to 500M and amendment to 2021 equity plan","bullets":["Authorized common shares increased from 150M to 500M; approved with 62.99M votes for, 26.50M against.","Amendment No. 1 to 2021 Stock Option and Incentive Plan approved with 46.37M for, 27.37M against, 15.75M broker non-votes.","Special Meeting held August 5, 2026; quorum of 89.49M shares represented."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-335157","json":"https://secwatch.observer/filing/0001193125-26-335157.json","markdown":"https://secwatch.observer/filing/0001193125-26-335157.md","text":"https://secwatch.observer/filing/0001193125-26-335157.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/0001193125-26-335157-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/aura-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:17:30.012962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}